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013.05.0Abstract Background: Infective endocarditis (IE) is associated with substantial morbidity and
mortality. However, there are conﬂicting views as to the signiﬁcance of bacteremia caused by inter-
ventional procedures in the existing clinical guidelines.
Objectives: Formal evaluation of risk factors for IE is lacking in Egyptian tertiary care centers. We
test the hypothesis that underlying medical conditions, not culprit procedures, are the most impor-
tant risk factor for development of IE.
Methods: We matched 175 patients with deﬁnite IE from IE database of the Cardiology Depart-
ment, Cairo University Hospital with175 control cases without IE, matched for age, sex, and under-
lying heart disease. Demographic and clinical data, comorbidities and potential culprit procedures
during the 3 months prior to the diagnosis of IE were recorded.
Results: Host-related risk factors included renal impairment (p< 0.001), renal dialysis (p= 0.003)
and prior episode of IE (p= 0.03). Procedure-related risk factors included a history of hospitalization
for at least 24 h in the preceding 3 months (p< 0.001), and use of peripheral intravenous line
(p= 0.005). Dental procedures were not risk factors for IE. Staphylococcus aureuswas the most preva-
lent procedure-related microorganism (27.3 %), followed by Streptococcus species in 15.9% of cases.
Conclusions: Hospitalization for at least 24 h within the preceding 3 months, peripheral IV line place-
ment, renal impairment andprior IEwere signiﬁcant risk factors for IE. Staphylococciwere the predom-
inantmicroorganisms. These results suggest a nosocomial source of infection and call for reinforcement
of infection prevention interventions in Egyptian hospitals especially in high-risk patients.
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041. Introduction
Infective endocarditis (IE) is associated with substantial mor-
bidity andmortality, despite improved techniques to aid diagno-
sis and modern antibiotics and surgical therapies.1 In
developing countries, rheumatic heart disease remains thegyptian Society of Cardiology.
154 W. Ammar et al.most frequent predisposing cardiac condition.2 However; the
epidemiological features of IE in developed countries have
changed considerably. The aging of the population has been
paralleled by increases in the prevalence of degenerative heart
valve disease, and in the use of implanted heart valve substi-
tutes and intracardiac devices. The numbers of patients with
chronic, predisposing medical comorbidities, such as diabetes,
HIV infection, and end-stage renal disease, have also in-
creased. Also, newer invasive therapeutic interventions partic-
ularly IV catheters, pacemakers, and dialysis shunts have all
increased the risk of bacteremia and subsequent endocarditis
in the population at risk.3–5
There are conﬂicting views as to the signiﬁcance of bacter-
emia caused by interventional procedures in existing clinical
guidelines. The AHA6 and ESC7 guidelines noted that tran-
sient bacteremia does not just follow dental and medical pro-
cedures but also occurs after events of daily living such as
mastication of food and brushing teeth, and most of the pub-
lished data used less sensitive microbiological methodology.
Furthermore, the Working Party of the British Society for
Antimicrobial Chemotherapy (BSAC) report highlighted that
the signiﬁcance of both the magnitude and duration of bacter-
emia is unknown.8 In contrast, the Advisory Group of the
British Cardiac Society/Royal Colleague of Physicians (BCS/
RCP) guideline considered that the risk of developing IE is
probably directly related to the frequency and severity of bac-
teremia that occurs with each individual procedure.9 Many IE
risk factors have been postulated, but formal evaluation of
these risk factors has not been performed in Egypt. We carried
out a retrospective case: control study to generate hypotheses
regarding risk factors for IE in Egyptian tertiary care centers
2. Patient and methods
The study involved 350 cases. One hundred and seventy-ﬁve
patients with deﬁnite IE according to modiﬁed Duke Criteria
for diagnosis of IE10 from the IE database of the Cardiology
Department at Cairo University Hospital from March 2005 till
June 2008 and 175 control cases without IE collected from the
Cairo University Hospital and the National Heart Institute,
Outpatient Clinic, and Family Medicine Clinic.
Control cases were matched to IE cases by age (±x years),
sex, and medical comorbidities including underlying heart dis-
ease and prosthetic valves. Patient consent was obtained and
patient’s medical records were abstracted onto structured
forms to capture clinical, imaging and laboratory information.Table 1 Clinical characteristic and underlying heart disease.
Variable IE Case
Number of patients 175
Age Mean ± Sd 32.13 ± 13.76
N %
Sex male 102 58.3%
Female 73 41.7%
Known structural heart disease 117 66.9%
Valvular heart disease 53 30.3%
Prosthetic valve 49 28.0%
Congenital heart disease 15 8.6%
No structural heart disease 58 33.1%A consented questionnaire was used to collect the clinical data
from the control cases.
The following history and clinical data were collected from
both IE cases and controls including:
(1) Age, sex, history of hospitalization (for at least 24 h)
within the last 3 months for indication unrelated to a
possible or deﬁnite diagnosis of IE, underlying valvular
heart disease, congenital heart disease, prosthetic valves
or intracardiac devices.
(2) Co-morbid conditions: such as diabetes mellitus, renal
impairment deﬁned as GFR< 60 ml/min/1.73 m2,11 renal
dialysis, prior IE, hepatic disease, drug abuse andmalignancy.
(3) Potential culprit procedures including: upper respiratory
tract procedures, upper and lower GI endoscopy, bar-
ium enema, gynecological surgery, urinary catheteriza-
tion, cardiac catheterization, device implantation,
peripheral and central intravenous lines and dental pro-
cedures (tooth extraction and any procedure involving
manipulation of the gingiva).
(4) The causative organism (if identiﬁed), in patients with
conﬁrmed IE.
3. Statistical analysis
Data were analyzed using the SPSS statistical package version
(17). Comparison between groups was by two-tailed unpaired
student’s t test for normally distributed, continuous variables
and Pearson’s chi-square test for categorical variables. Corre-
lations between normally distributed variables were done using
Pearson’s correlation coefﬁcient. A probability value (p value)
less than 0.05 was considered signiﬁcant. There was no correc-
tion for multiple testing.
4. Results
4.1. Clinical characteristics of study population Table 1
4.2. Host related risk factors
We found that IE cases were more likely than controls to suffer
from renal impairment (p value <0.001). (Table 2) IE casesControl P value
175
32.90 ± 12.12 N.S
N %
103 58.9% N.S
72 41.1% N.S
111 63.4% N.S
54 30.9% N.S
45 25.7% N.S
12 6.9% N.S
64 36.6% N.S
Table 2 Medical co-morbidities associated with increased risk of IE.
Host related risk factors IE cases Controls P value Odd ratio and 95% conﬁdence Interval
N % N %
Renal impairment 21 12.0% 2 1.1% <0.001 11.795(2.72–51.125)
Renal dialysis 11 6.3% 1 0.6% 0.003 11.67 (1.49–91.403)
DM 11 6.3% 4 2.3% 0.065 2.867 (0.895–9.186)
Prior endocarditis 9 5.1% 2 1.1% 0.032 4.69 (0.998–22.027)
Hepatic disease 7 4.0% 1 0.6% 0.067 7.25 (0.883–59.56)
Drug abuse 12 6.8% 0 0 NS
Malignancy 4 2.3% 2 1.1% NS
Others (thalassemia, steroid and CTD) 8 4.6% 2 1.1% 0.054 4.144(0.867– 19.79)
CTD: connective tissue disease.
Table 3 Procedure-related risk factors.
Culprit procedure Case Control P value Odds ratio
n % n %
Hospitalization in last 3 months 74 42.3% 26 14.9% <0.001 4.2 (2.5–7.02)
Upper respiratory tract procedures 0 0% 2 1.1% NS
Gynecological surgery 1 0.6% 4 2.3% NS
Urinary catheterization 2 1.1% 6 3.4% NS
Other genitourinary procedures 1 0.6% 0 0% NS –
Cardiac catheterization 3 1.7% 4 2.3% NS
Peripheral intravenous line 32 18.2% 14 8.2% 0.005 2.78 (1.32–5.02)
Central I.V. line 4 2.3% 2 1.1% NS
Dental procedure 6 3.4% 8 4.6% NS
Other surgeries 2 1.1% 1 0.6% NS
Table 4 Signiﬁcant predictors of IE (adjusted for age and
sex).
Predictors of IE P value Odd ratio 95.0% C.I.
Lower Upper
History of hospitalization <0.001 3.966 2.325 6.764
Renal impairment 0.004 9.007 1.980 40.966
Prior IE 0.029 5.841 1.201 28.411
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trols (p value = 0.003) and to have had a prior episode of IE (p
value = 0.03).
4.3. Procedure-related risk factors
In our study, 74 of 175 (42.3%) IE cases reported hospitaliza-
tion for at least 24 h in the preceding 3 months, compared to
26 of 175 (14.9%) control cases. (p< 0.001). (Table 3) We
ascertained that the indication for prior hospitalization was a
variety of medical or surgical reasons unrelated to either IE
or misdiagnosis of IE on prior hospitalization. IE cases were
also more likely than controls to report placement of periphe-
ral IV lines during the preceding hospitalization. The fre-
quency of all other potential culprit procedures was not
signiﬁcantly different between IE cases and controls. Upper
or lower GI endoscopy and barium enema were not reported
in either group.Following multivariate analysis, only history of hospitaliza-
tion (for at least 24 h), renal impairment, and prior IE re-
mained signiﬁcant predictors of IE (adjusted for age and
sex). (Table 4)
4.4. Organism identiﬁed and culprit procedure related organisms
The causative organism was identiﬁed in 88 IE cases (50.2%). A
culprit procedure in the preceding 3 months was reported in 60
cases with identiﬁedmicroorganisms. (Table 5). Of the 13 IE pa-
tients with Staphylococcus aureus infection, six had undergone
vessel cannulation as a possible culprit procedure. Of the eight
IE patients with conﬁrmed infection with Streptococcus viri-
dans, a common oral commensal none had had a preceding den-
tal procedure in the 3 months prior to the onset of their IE.
5. Discussion
In this case: control study of Egyptian patients with IE in a ter-
tiary care setting, hospitalization in the 3 months prior to IE
onset, renal impairment, and antecedent IE were independent
risk factors for IE.
Our study conﬁrms published observations by others
regarding renal impairment and previous IE as risk factors
for IE. In one large cohort study, recurrent endocarditis oc-
curred in 4.5% of patients who survived their initial episode.12
Other studies have reported rates of IE recurrence up to 9%.13
Strom et al., in a population-based case–control study, stated
Table 5 Organisms related to culprit procedures.
History of hospitalization I.V line Dental procedures Renal dialysis Cardiac catheterization Other surgery
S. aureus 13 4 2 2 – –
S. coagulase- negative 5 1 1 – – 1
Strep. viridans 8 2 – 1 – –
Enterococci 4 1 – – 1 –
Bartonella 4 – – 1 – –
C. albicans 0 – – – – –
Candida spp. 1 1 – – – –
Aspergillus 5 1 – 1 –
Total 40 10 3 5 1 1
S. aureus: Staphylococcus aureus; S. coagulase- negative: coagulase- negative staphylococci; C. albicans: Candida albicans
156 W. Ammar et al.IE cases were more likely than controls to suffer from prior re-
nal insufﬁciency (P= 0.02) and diabetes mellitus (P= .004).14
Intravenous drug use is a well-established risk factor for IE
caused by S. aureus. Caution must be exercised when interpret-
ing the high rate of S. aureus IE in our study populations and
the low rate of a history of intravenous drug use. The cultural
stigma associated with drug abuse may have inhibited patients
from volunteering that relevant medical history.
Procedure-related risk factors are thought to be linked to
endocarditis through induction of bacteremia and seeding of
heart valves; and antibiotic prophylaxis is often considered
in conjunction with such procedures. Procedures causing
healthcare-associated IE were reported to represent up to
30% of all cases of IE and are characterized by an increasing
incidence and a severe prognosis, thus representing an impor-
tant health problem.15 In our study, 74 cases (42.3%) were
hospitalized for at least 24 h within the preceding three months
compared to only 26 cases (14%) in the control group
(p< 0.001).
Nosocomial infective endocarditis has been deﬁned as acute
IE occurring 48–72 h or more post-admission to hospital.
Using a broader deﬁnition in one series, the incidence rate of
IE in the 6-month period after discharge from the hospital
was 27 cases per 100,000 person-years, compared with 11 cases
per 100,000 person-years in a population with no recent hospi-
talizations. Furthermore, episodes of IE manifesting during
this 6-month period were notable for a high proportion of typ-
ically hospital-acquired pathogens (26% vs. 0%; P= .001)
and a low proportion of viridans streptococci (0% vs. 36%;
P< 001), compared with community-acquired episodes that
did not involve recent hospitalization.16,17
Intravascular catheters are playing an increasing role in
nosocomial IE. In a prospective case–control study of hospital-
ized Danish patients, the presence of a central venous catheter
was the single greatest risk factor for the development of S.
aureus bacteremia (SAB).18 Use of central IV catheters was
rare in our study population. However, IE cases were more
likely than controls to report a peripheral IV catheter,
(18.2% vs. 8.2%. p value = 0.005). This is an alarming ﬁnd-
ing, as peripheral IV catheter, though a simple procedure
may be a signiﬁcant risk factor for nosocomial IE. Although
routine antimicrobial prophylaxis administered before most
invasive procedures is not recommended, aseptic measures
during the insertion and manipulation of venous catheters
and during any invasive procedures are mandatory to reduce
the rate of bacteremia.7No association was found between IE and dental proce-
dures in our small series. These ﬁndings are concordant with
an evidence statement from National Institute for Health
and Clinical Excellence (NICE), which concluded that there
was no consistent association between dental and non-dental
procedures and the development of infective endocarditis.19
In agreement with our ﬁndings, population based case–control
studies that considered dental risk factors,20 oral hygiene and
non-dental procedures,14 showed no signiﬁcant increased risk
with dental treatment, no association was found between IE
and the frequency of routine dental care within the previous
year, tooth brushing or use of toothpicks. Taken together,
these studies support the current recommendations to with-
hold antibiotic prophylaxis prior to invasive dental or medical
procedures for patients with increased risk of IE. Rather, the
current recommendations appropriately stress the importance
of patient education regarding medical conditions that predis-
pose to IE and the importance of obtaining blood cultures in
the setting of fever without a deﬁned source.
No invasive medical procedures were signiﬁcantly associ-
ated with development of IE. An update to the ACC/AHA
guidelines21 noted that conclusive links have not been demon-
strated between respiratory tract, GI, or GU procedures. Fur-
thermore, the BSAC guideline8 noted that there are no good
epidemiological data on the impact of bacteremia from non-
dental procedures on the risk of developing endocarditis.
Staphylococci species especially S. aureus was the most pre-
valent causative and procedure-related microorganism in our
study (27.3%), followed by Streptococcus species in 15.9% of
cases. This shift of pattern from the usual prevalence of strep-
tococci has been reported in other studies as staphylococci
have exceeded the streptococci species in causing IE with con-
comitant decrease in the incidence of viridans streptococci.22,23
Finally the retrospective nature of the study and inherited bias
of self reporting of data could be limitations to the present
study.
6. Conclusions
History of hospitalization for at least 24 h within the preceding
3 months and peripheral IV line placement were risk factors
for IE in Egyptian patients. Regarding host-related risk fac-
tors, our study conﬁrmed renal impairment and prior IE as
risk factors for IE. Staphylococci were the predominant micro-
organisms regarding the etiology of the IE and procedure re-
lated organism.
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